DR. BARRY GOLDENBERG, MD PC
Medical Practice at End Ave, New York, NY

License number

New York 131085

Personal information

See more information about BARRY GOLDENBERG at radaris.com

Name

Address

Phone

Barry Goldenberg, age 73

3 Candlewood Ct, Scarsdale, NY 10583

(914) 860-5307

Barry Goldenberg, age 65

40 Saldo Cir, New Rochelle, NY 10804

Barry Goldenberg, age 54

2 Soulagnet Ct, Dix Hills, NY 11746

(516) 643-7807

Barry Goldenberg, age 69

24 Merit Ln, Jericho, NY 11753

(516) 448-6439

Barry Goldenberg

200 E End Ave APT 6I, New York, NY 10128

Organization information

See more information about BARRY GOLDENBERG at bizstanding.com

Barry Goldenberg MD PC

200 E End Ave, New York, NY 10128

Industry:

Hospital & Health Care, Medical Doctor's Office

Site:

drbarrygoldenberg.com

Phone:

(212) 987-4600 (Phone)

Description:

Dr Barry Goldenberg MD is a board certified sergeon who performs wide array of surgical and non-surgical cosmetic and plastic surgery including breast augmentation, facelift, liposuction, tummy tuck, ...

President, Surgery-Plastic, Md Pc , Medical Doctors:

Jeanne A. Romero (Office Manager),Johanna M. Kiley (Registered Nurse),Bruce Goldenberg (Md Pc , Medical Doctor, Plastic Surgeon, Surgery-Plastic),...

BARRY GOLDENBERG, M.D., PC

169 E 69 St, New York, NY 10021

Registration:

Jul 30, 1984

State ID:

933538

Business type:

DOMESTIC PROFESSIONAL CORPORATION

Barry Goldenberg Md, 169 E 69 St, New York, NY 10021 (Physical)

Professional information

Senior Mortgage Loan Originator At Luxury Mortgage Corp

Position:

Senior Mortgage Loan Originator at Luxury Mortgage Corp

Location:

Greater New York City Area

Industry:

Financial Services

Work:

Luxury Mortgage Corp - Garden City, New York since Feb 2012 - Senior Mortgage Loan Originator Mortgage Master Feb 2010 - Feb 2012 - Senior Loan Officer GuardHill Financial Corp. Jul 2008 - Feb 2010 - Vice President Indymac Bank Nov 2007 - Jul 2008 - Vice President/Senior Loan Officer MortgageIT Sep 2004 - Nov 2007 - Regional Sales Manager/Loan Officer New York Mortgage Company Feb 2000 - Aug 2004 - Loan Officer

Education:

University of Maryland College Park 1988 - 1992
BS, Criminal Justice

Skills:

Mortgage Banking, Mortgage Lending, Co-op Financing, FHA financing, Condos, New Construction Homes, Purchase, Refinance Transactions, Loan Origination, Creative Problem Solving, First Time Home Buyers, Residential Mortgages, Social Networking, Real Estate Financing, Finance, Construction, Investment Properties, Refinance, Real Estate Transactions, Investors, Loans, Real Estate Economics, FHA, Selling, Credit, Referrals

Director Of Sales &Amp; Marketing, Codestreet Llc

Position:

Director of Sales & Marketing at CodeStreet LLC

Location:

Greater New York City Area

Industry:

Capital Markets

Work:

CodeStreet LLC since Aug 2007 - Director of Sales & Marketing Bridge the Gap Consulting, LLC Sep 2006 - Aug 2007 - Principal MarketAxess Corp Mar 2000 - May 2006 - Head of Product Management and Development JP Morgan Securities Dec 1986 - Feb 1999 - Head of IG, ABS and AGY Trading Desks Lloyds Bank PLC Apr 1985 - Dec 1986 - Vice President- Eurobond Sales Continental Bank May 1983 - Apr 1985 - Associate- Money Market Sales

Education:

The University of Chicago - Booth School of Business 1981 - 1983
MBA, Finance, Accounting University of Rochester 1977 - 1981
BA, Economics

Skills:

Electronic Trading, Fixed Income, Credit, Hg, Trading Systems, Start-ups, Market Data, Trading, Capital Markets, Credit Derivatives, Bloomberg, Emerging Markets

Enhanced Soft Tissue Flap Survival In Reconstructive Surgery

US Patent:

4599340, Jul 8, 1986

Filed:

May 7, 1985

Appl. No.:

6/731363

Inventors:

Lester Silver - Englewood NJ
Barry Goldenberg - New York NY

Assignee:

Miles Laboratories, Inc. - Elkhart IN

International Classification:

A61U 3155, A61U 31135, A61U 31275, A61U 31435, A61U 31495

US Classification:

514277

Abstract:

A method for reducing soft tissue flap necrosis in a patient undergoing reconstructive surgery is disclosed. The method comprises administering to such patient an effective amount of a calcium channel blocking drug or a pharmaceutically acceptable non-toxic salt thereof to reduce said necrosis of said flap. Also disclosed are pharmaceutical compositions suitable for use in reducing soft tissue flap necrosis.